Abbott ABT Medical Devices — Selling, general, and administrative

Other segment segments

Similar metrics at other companies

STEHealthcare — Selling, general, and administrative

$170.5M+10.3%

ALife Sciences and Diagnostics Markets — Selling, General and Administrative Expense

$170M+8.3%

IQVOperating Segments — Selling General And Administrative Expense

$359M+12.5%

BSXMedSurg — Selling, general and administrative expenses, percentage of net sale

32.8%+1.0pp

STELife Sciences: — Selling, general, and administrative

$15.6M+4.0%

VRSKOperating Segments — Selling General And Administrative Expense

$77.81M+10.2%

Questions, answered.

What is Abbott's medical devices — selling, general, and administrative?

Abbott (ABT) reported medical devices — selling, general, and administrative of $1.39B in Q1 2026.

How has Abbott's medical devices — selling, general, and administrative changed year-over-year?

Abbott's medical devices — selling, general, and administrative increased by 7.8% year-over-year, from $1.29B to $1.39B.

What is the long-term trend for Abbott's medical devices — selling, general, and administrative?

Over 3 years (2022 to 2025), Abbott's medical devices — selling, general, and administrative has grown at a 10.2% compound annual growth rate (CAGR), from $4.07B to $5.45B.

What does medical devices — selling, general, and administrative mean?

The operating expenses related to selling products and managing the business, excluding production costs.

How do you interpret medical devices — selling, general, and administrative?

Lower spending relative to revenue suggests improved operational efficiency and better cost management.

How does medical devices — selling, general, and administrative compare across companies?

Standard SG&A expense metric used across all industries.